Thank you very much for your email of the 11thMay concerning the position of NICE in relation to the treatment of chronic myeloid leukaemia.
I am so very sorry to hear about your diagnosis.
As you are aware the consultation on the appraisal committee’s preliminary recommendations ends on the 27thMay and the appraisal committee is due to meet on the 9thJune. The appraisal committee’s preliminary recommendations are not NICE’s final guidance on these technologies and their recommendations may change after the consultation.
I am very taken with the power of your email and I am today writing to the Minister of State for Health to convey the very powerful points that you have raised and I will of course come back to you when I have received his response.
In the meantime I have copied below a Parliamentary Written Question that my colleague, James Clappison MP, tabled on the therapies for rare cancers in the NHS:-
Mr Clappison:To ask the Secretary of State for Health what assessment he has made of the capacity of the National Institute for Health and Clinical Excellence to carry out appraisals for innovative inhibitor therapies for rare cancers; what recent assessment he has made of the availability of such therapies; and if he will make a statement. [57177]
Paul Burstow:The National Institute for Health and Clinical Excellence (NICE) has appraised, or is appraising, a number of inhibitor therapies for less common cancers. Full information on NICE'S appraisal methodology is available in its “Guide to the Methods of Technology Appraisal”, available at:
Primary care trusts are legally obliged to fund drugs and treatments recommended in NICE technology appraisal guidance, within three months of guidance being published, unless the requirement is waived in a specific case.
We also launched the Cancer Drugs Fund in April 2011, which makes £200 million available in each of the next three years to help thousands more cancer patients access the drugs their clinicians believe will help them. [23rdMay 2011]
Thank you very much for contacting me and I will of course come back to you as soon as I have heard back from the Minister.
Yours sincerely,
Nicholas Soames